IL2RA Methylation and Gene Expression in Relation to the Multiple Sclerosis-Associated Gene Variant rs2104286 and Soluble IL-2Rα in CD8+ T Cells
- PMID: 34386002
- PMCID: PMC8353370
- DOI: 10.3389/fimmu.2021.676141
IL2RA Methylation and Gene Expression in Relation to the Multiple Sclerosis-Associated Gene Variant rs2104286 and Soluble IL-2Rα in CD8+ T Cells
Abstract
CD8+ T cells are involved in the pathogenesis of multiple sclerosis (MS). The interleukin-2 receptor α (IL-2Rα) is important for CD8+ T cell function, and single nucleotide polymorphisms (SNPs) in the IL2RA gene encoding IL-2Rα increase the risk of MS. Therefore, in isolated CD8+ T cells we investigated IL2RA gene methylation and gene expression in relation to the MS-associated IL2RA SNP rs2104286 and soluble IL-2Rα (sIL-2Rα). We have identified allele specific methylation of the CpG-site located in intron 1 that is perturbed by the rs2104286 SNP in CD8+ T cells from genotype-selected healthy subjects (HS). However, methylation of selected CpG-sites in the promotor or 5'UTR region of the IL2RA gene was neither associated with the rs2104286 SNP nor significantly correlated with IL2RA gene expression in HS. In CD8+ T cells from HS, we explored expression of immune relevant genes but observed only few associations with the rs2104286 SNP. However, we found that sIL-2Rα correlated negatively with expression of 55 immune relevant genes, including the IL-7 receptor gene, with Spearman's rho between -0.49 and -0.32. Additionally, in HS by use of flow cytometry we observed that the IL-7 receptor on naïve CD8+ T cells correlated negatively with sIL-2Rα and was downregulated in carriers of the rs2104286 MS-associated risk genotype. Collectively, our study of resting CD8+ T cells indicates that the rs2104286 SNP has a minor effect and sIL-2Rα may negatively regulate the CD8+ T cell response.
Keywords: CD8+ T cells; IL-7 receptor alpha; IL2RA; allele specific methylation; interleukin-2 receptor alpha; multiple sclerosis; rs2104286; sCD25.
Copyright © 2021 Buhelt, Laigaard, von Essen, Ullum, Oturai, Sellebjerg and Søndergaard.
Conflict of interest statement
SB has received support for congress participation from Biogen and Merck. H-ML currently works at AGC Biologics but had no conflicts of interest at the time of performing the study described in this paper. AO has served on scientific advisory boards for Biogen Idec, Novartis, and Sanofi Genzyme; has received research support from Novartis and Biogen Idec; has received speaker honoraria from Biogen Idec, Novartis and TEVA; and has received support for congress participation from Merck, TEVA, Biogen, Roche, Novartis, and Sanofi Genzyme. FS has served on scientific advisory boards for, served as consultant for, received support for congress participation or received speaker honoraria from Alexion, Biogen, Merck, Novartis, Roche, and Sanofi Genzyme. His laboratory has received research support from Biogen, Merck, Novartis, Roche, and Sanofi Genzyme. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Biomarkers of systemic inflammation, soluble IL-2Rα and the multiple sclerosis-associated IL2RA SNP rs2104286 in healthy subjects and multiple sclerosis patients.Mult Scler Relat Disord. 2021 Sep;54:103140. doi: 10.1016/j.msard.2021.103140. Epub 2021 Jul 7. Mult Scler Relat Disord. 2021. PMID: 34304016
-
Relationship between Multiple Sclerosis-Associated IL2RA Risk Allele Variants and Circulating T Cell Phenotypes in Healthy Genotype-Selected Controls.Cells. 2019 Jun 25;8(6):634. doi: 10.3390/cells8060634. Cells. 2019. PMID: 31242590 Free PMC article.
-
Relationship between soluble CD25 and gene expression in healthy individuals and patients with multiple sclerosis.Cytokine. 2017 May;93:15-25. doi: 10.1016/j.cyto.2017.04.024. Epub 2017 May 13. Cytokine. 2017. PMID: 28511943 Clinical Trial.
-
Association of IL2RA and multiple sclerosis risk: A case control, systematic review, and meta-analysis study.J Neurol Sci. 2025 May 15;472:123461. doi: 10.1016/j.jns.2025.123461. Epub 2025 Mar 10. J Neurol Sci. 2025. PMID: 40086235
-
The soluble IL-2 receptor α/CD25 as a modulator of IL-2 function.Immunology. 2024 Mar;171(3):377-387. doi: 10.1111/imm.13723. Epub 2023 Nov 30. Immunology. 2024. PMID: 38037265 Review.
Cited by
-
Exon-intron split analysis reveals posttranscriptional regulatory signals induced by high and low n-6/n-3 polyunsaturated fatty acid ratio diets in piglets.J Anim Sci. 2023 Jan 3;101:skad271. doi: 10.1093/jas/skad271. J Anim Sci. 2023. PMID: 37561402 Free PMC article.
-
The Role of Oligodendrocytes in Neurodegenerative Diseases: Unwrapping the Layers.Int J Mol Sci. 2025 May 12;26(10):4623. doi: 10.3390/ijms26104623. Int J Mol Sci. 2025. PMID: 40429767 Free PMC article. Review.
-
The Polygenic Nature of Multiple Sclerosis: Genetic Variants, Immunological Modulation, and Environmental Connections.Endocr Metab Immune Disord Drug Targets. 2025;25(7):527-559. doi: 10.2174/0118715303325979241206115417. Endocr Metab Immune Disord Drug Targets. 2025. PMID: 39810445 Review.
-
KIAA0101 and IL2RA Were Identified as Core Genes in Hormone-Resistant Nephropathy.Dis Markers. 2022 Sep 17;2022:6545266. doi: 10.1155/2022/6545266. eCollection 2022. Dis Markers. 2022. PMID: 36164371 Free PMC article.
-
Identification of crucial inflammaging related risk factors in multiple sclerosis.Front Mol Neurosci. 2024 May 21;17:1398665. doi: 10.3389/fnmol.2024.1398665. eCollection 2024. Front Mol Neurosci. 2024. PMID: 38836117 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials